Redcliffe Labs’ AI-Powered Face Scan Flags Early Health Risks; Follow-Up Testing Validates Concerns in Nearly 9 Out of 10 Users

  • 62% of users showed blood pressure variability, 48% recorded elevated stress levels, and 36% exhibited breathing irregularities; follow-up diagnostic testing revealed abnormalities linked to cardiovascular, inflammatory, metabolic, and nutritional health in the majority of users
  • Face Scan assessments indicate that physiological signals visible on the face may provide early indications of underlying health concerns, encouraging timely preventive action

New Delhi, 25 June 2026: India is witnessing a growing burden of lifestyle disorders, yet a large proportion of health conditions continue to remain undetected until symptoms appear. An analysis conducted by Redcliffe Labs on data generated through its AI-powered Face Scan platform suggests that the body may begin signalling potential health concerns much earlier than most individuals realise.

Over the past six months, lakhs of individuals have used Redcliffe’s Face Scan, a non-invasive digital health assessment tool designed to identify physiological indicators of overall well-being. The findings reveal a concerning trend. Nearly 62% of overall face scan users showed signs of blood pressure variability, 48% recorded elevated stress levels, while 36% exhibited breathing-rate irregularities.

The findings became particularly significant when users acted on these early signals. A substantial proportion of Face Scan users proceeded with the recommended laboratory investigations after completing the assessment, and nearly 9 out of 10 were found to have abnormalities in the corresponding diagnostic health parameters. The findings indicate a strong correlation between the physiological indicators identified by Face Scan and the underlying health concerns detected by laboratory investigations.

The validated diagnostic findings clustered around four key health areas:

Cardiovascular Health: Follow-up investigations frequently revealed abnormalities in LDL cholesterol, HDL cholesterol, and triglycerides, indicating underlying cardiovascular risk factors that often remain undetected until later stages. Lipid and cholesterol-related abnormalities accounted for 7 of the 10 most frequently deranged health markers identified during follow-up testing.

Systemic Inflammation: Over one in five individuals exhibited elevated hs-CRP levels, while abnormalities in ESR and other immune-related markers were also frequently observed. The findings point towards low-grade systemic inflammation, a known contributor to cardiovascular disease, metabolic disorders, and several chronic health conditions.

Nutritional Health: More than half of the individuals exhibited abnormal Vitamin D levels, while blood health abnormalities and other nutritional imbalances were also commonly observed among users whose Face Scan indicated potential health risks. The findings highlight the widespread prevalence of hidden nutritional deficiencies that often go unnoticed without routine screening.

Metabolic & Organ Health: Follow-up investigations also identified abnormalities in blood sugar markers, liver enzymes, and kidney function parameters, indicating broader metabolic health concerns that may otherwise go unnoticed for years.

The findings highlight the growing role of AI-enabled preventive health technologies in encouraging earlier diagnostic action. While Face Scan is not a diagnostic tool and does not replace laboratory investigations, it can serve as an early screening mechanism that encourages individuals to seek timely testing before symptoms become apparent.

Commenting on the findings, Aditya Kandoi, Founder & CEO, Redcliffe Labs, said, “For far too long, healthcare has begun when illness becomes visible. The future lies in helping people identify risks earlier and act sooner. The validation of Face Scan findings through diagnostic testing demonstrates the potential of combining technology with preventive healthcare to enable more informed health decisions. Ultimately, our goal is simple: to help people stay healthier for longer, not just treat disease after it appears.”

As cardiovascular diseases, metabolic disorders, and lifestyle-related conditions continue to affect Indians at younger ages, technologies that encourage earlier health assessment could play an important role in shifting healthcare from reactive treatment towards preventive care. The analysis reinforces a simple but important message: many health risks develop silently, but recognizing early physiological changes and following them up with appropriate diagnostic testing can significantly improve the opportunity for timely intervention.

About Redcliffe Labs

Redcliffe Labs is an impact-driven, fastest-growing diagnostic healthcare provider redefining healthcare access across India to add Healthy Years to Lives. Having served over 1 crore customers to date, the company operates with a preventive-first approach across 220+ cities through 80+ owned advanced laboratories and coverage of 4,000+ pincodes, offering 3,600+ diagnostic tests powered by clinical expertise and AI-led innovation. With convenient home sample collection, smart health insights, and personalized wellness solutions, Redcliffe Labs offers a complete care plan that delivers 4X the benefits with every test, enabling earlier risk detection and better health every day.

Share